What is the difference between Conn's (primary aldosteronism) syndrome and Liddle syndrome in terms of underlying causes, symptoms, and treatment options?

Conn's Syndrome vs. Liddle Syndrome: Key Differences

Conn's syndrome (primary aldosteronism) and Liddle syndrome are fundamentally different conditions: Conn's involves excessive aldosterone production from the adrenal glands, while Liddle syndrome results from a genetic defect in kidney sodium channels that mimics aldosterone excess without any aldosterone elevation. 1, 2, 3

Underlying Pathophysiology

Conn's Syndrome (Primary Aldosteronism)

• Caused by autonomous aldosterone overproduction from either an adrenal adenoma (30% of cases) or bilateral adrenal hyperplasia (70% of cases) 4
• The excess aldosterone drives sodium retention and potassium excretion in the distal nephron 4
• Represents the most common form of secondary hypertension, affecting approximately 3% of hypertensive patients 5, 6

Liddle Syndrome

• Results from genetic mutations in the epithelial sodium channel (ENaC) subunits (β or γ subunits) that prevent normal channel degradation 7, 2, 3
• These mutations prevent ubiquitination of ENaC subunits, causing excessive sodium channels to remain in the cell membrane and increasing sodium reabsorption 3
• This creates a state of aldosterone-independent sodium retention—the kidneys act as if aldosterone is present when it is not 6, 8
• Inherited in an autosomal dominant pattern and typically presents early in life, often in childhood 1, 2, 9

Clinical Presentation

Shared Features (Both Conditions)

• Hypertension (often severe and early-onset) 4, 9, 6
• Hypokalemia with metabolic alkalosis 4, 9, 3
• Muscle weakness, fatigue, polyuria, and polydipsia 9, 6

Distinguishing Clinical Features

• Liddle syndrome often presents in childhood or adolescence, whereas Conn's syndrome typically presents in the fourth to fifth decade 2, 9
• Liddle syndrome may be associated with nephrocalcinosis and progressive renal failure from long-standing hypertension 9

Diagnostic Biochemical Profile

Conn's Syndrome

• Elevated plasma aldosterone concentration 4
• Suppressed plasma renin activity (PRA) 4, 5, 4
• Aldosterone-to-renin ratio typically >30 4
• Urinary potassium excretion >30 mmol/24h despite hypokalemia 6
• Confirmatory testing with saline suppression test or salt loading test shows failure to suppress aldosterone 4

Liddle Syndrome

• Suppressed plasma aldosterone levels 2, 9, 8, 3
• Suppressed plasma renin activity 9, 8, 3
• Both aldosterone AND renin are low—this is the critical distinguishing feature 6, 8
• Hypokalemia may be present but can sometimes be normal 6
• Genetic testing confirms mutations in SCNN1B or SCNN1G genes (encoding ENaC β or γ subunits) 2, 3

The key diagnostic distinction: In Conn's syndrome, aldosterone is HIGH with low renin; in Liddle syndrome, BOTH aldosterone and renin are LOW. 6, 8, 3

Treatment Approaches

Conn's Syndrome Treatment Algorithm

For unilateral disease (adenoma):

• Laparoscopic adrenalectomy is the treatment of choice and potentially curative 4, 10
• Adrenal vein sampling should be performed to confirm lateralization before surgery 4

For bilateral disease (hyperplasia) or non-surgical candidates:

• Spironolactone 50-100 mg daily, titrated up to 300-400 mg daily as needed 4, 10
• Eplerenone can be used as an alternative for patients intolerant of spironolactone side effects 4, 11, 10
• Monitor potassium and creatinine within 2-3 days and at 7 days after initiation, then monthly for 3 months 10

Liddle Syndrome Treatment Algorithm

Spironolactone and other aldosterone antagonists are INEFFECTIVE in Liddle syndrome because the problem is not aldosterone excess 9, 8, 3

First-line treatment:

• Amiloride (5-30 mg daily) or triamterene to directly block ENaC channels 9, 6, 8, 3
• Low sodium diet (<2.4 g sodium/day) is essential 9, 8, 3
• This combination can restore normotension and correct electrolyte abnormalities 8, 3

Definitive treatment:

• Kidney transplantation completely corrects hypertension and hypokalemia, confirming the tubular origin of the disease 9

Critical Pitfalls to Avoid

• Do not treat Liddle syndrome with spironolactone—it will fail because aldosterone is already suppressed 9, 8
• Do not assume hypokalemia must be present in either condition; normokalaemic forms exist and are increasingly recognized 5, 12
• Always measure BOTH aldosterone AND renin when evaluating mineralocorticoid hypertension—measuring only one can lead to misdiagnosis 4, 6
• Consider genetic testing for Liddle syndrome in young patients with hypertension, suppressed renin and aldosterone, especially with family history 2, 3
• Screen for familial hyperaldosteronism type I (glucocorticoid-remediable aldosteronism) in Conn's syndrome patients, as it requires different treatment with dexamethasone 2, 6, 12